Rossari Biotech Ltd Q1FY22 consolidated PAT higher at Rs. 24.52 crores

Rossari Biotech Ltd has reported financial results for the period ended June 30, 2021.

Financial Results (Q1 FY2021-22) - QoQ Comparison

The company has reported total income of Rs.234.18 crores during the period ended June 30, 2021 as compared to Rs.221.10 crores during the period ended March 31, 2021.

The company has posted net profit / (loss) of Rs.24.52 crores for the period ended June 30, 2021 as against net profit / (loss) of Rs.22.42 crores for the period ended March 31, 2021.

The company has reported EPS of Rs.4.49 for the period ended June 30, 2021 as compared to Rs.4.29 for the period ended March 31, 2021.

Financials	Q1 FY2021-22	Q4 FY2020-21	% Change
Total Income	₹ 234.18 crs	₹ 221.10 crs	5.92%
Net Profit	₹ 24.52 crs	₹ 22.42 crs	9.37%
EPS	₹ 4.49	₹ 4.29	4.66%

Financial Results (Q1 FY2021-22) - YoY Comparison

The company has reported total income of Rs.234.18 crores during the period ended June 30, 2021 as compared to Rs.111.06 crores during the period ended June 30, 2020.

The company has posted net profit / (loss) of Rs.24.52 crores for the period ended June 30, 2021 as against net profit / (loss) of Rs.15.49 crores for the period ended June 30, 2020.

The company has reported EPS of Rs.4.49 for the period ended June 30, 2021 as compared to Rs.3.14 for the period ended June 30, 2020.

Financials	Q1 FY2021-22	Q1 FY2020-21	% Change
Total Income	₹ 234.18 crs	₹ 111.06 crs	110.86%
Net Profit	₹ 24.52 crs	₹ 15.49 crs	58.3%
EPS	₹ 4.49	₹ 3.14	42.99%

Source : Equity Bulls

Keywords